Trials / Conditions / Thrombocytopenic Purpura
Thrombocytopenic Purpura
6 registered clinical trials studyying Thrombocytopenic Purpura.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Lymphocyte Counts in Immune Thrombocytopenic Purpura NCT03244410 | Assiut University | — |
| Completed | Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients NCT01444417 | Amgen | Phase 3 |
| Completed | Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura NCT00415532 | Amgen | Phase 3 |
| Completed | Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura NCT00454857 | Amgen | — |
| Completed | An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP NCT00508820 | Amgen | Phase 3 |
| Completed | Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura ( NCT00117143 | Amgen | Phase 1 / Phase 2 |